These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3705715)

  • 1. Prostaglandin therapy at the local level for neonates with critical heart defects.
    Zellers TM; Gutgesell HP
    Va Med; 1986 Mar; 113(3):162-4. PubMed ID: 3705715
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT; Norton JB; Readinger RI; Sotomora RF
    J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prostaglandin E1 in newborn infants with ductus-dependent heart diseases. Review of 40 cases].
    Simões LC; Sarachaga IH; Quero M; Casanova M; Cazzaniga M; Villibre D
    Arq Bras Cardiol; 1985 Jul; 45(1):31-6. PubMed ID: 3938651
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandin treatment of newborns with ductal-dependent congenital heart disease.
    Linday LA; Engle MA
    Pediatr Ann; 1981 Apr; 10(4):29-38. PubMed ID: 7232040
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostaglandin E1 in infants with critical congenital heart disease.
    Dungan WT
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Jan; 1(1):71-4. PubMed ID: 2454319
    [No Abstract]   [Full Text] [Related]  

  • 6. Supportive and emergency use of prostaglandin in the neonate with congenital heart disease.
    Hussain A; al Khudhairi D
    Middle East J Anaesthesiol; 1993 Feb; 12(1):73-81. PubMed ID: 8316154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nursing care of the neonate receiving prostaglandin E1 therapy.
    Rikard DH
    Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E1 use during neonatal transfer: potential beneficial role in persistent pulmonary hypertension of the newborn.
    Gupta N; Kamlin CO; Cheung M; Stewart M; Patel N
    Arch Dis Child Fetal Neonatal Ed; 2013 Mar; 98(2):F186-8. PubMed ID: 23235993
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined prostaglandin therapy and ductal formalin infiltration in neonatal pulmonary oligemia.
    Larson JE; Fleming WH; Sarafian LB; Rogler WC; Hofschire PJ; McManus BM
    J Thorac Cardiovasc Surg; 1985 Dec; 90(6):907-11. PubMed ID: 4068741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostaglandin treatment of ductus-dependent congenital heart defects].
    Olsson B; Björkhem G; Lundström NR
    Lakartidningen; 1984 Oct; 81(40):3619-22. PubMed ID: 6541738
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical pharmacologic management in the emergency department.
    Rosenberg NM; Powell EC; Lennarz WM; Stanley R
    Pediatr Emerg Care; 1998 Oct; 14(5):376-9. PubMed ID: 9814412
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
    Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
    J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].
    Fujii S; Nagai I; Yonei A; Sari A; Baba K
    Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818
    [No Abstract]   [Full Text] [Related]  

  • 14. Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease.
    Smet MH; Marchal G; Lambert L; Devlieger H; Gewillig M
    J Belge Radiol; 1989 Oct; 72(5):377-80. PubMed ID: 2600053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of gastric distention to prostaglandin therapy in neonates.
    Kriss VM; Desai NS
    Radiology; 1997 Apr; 203(1):219-21. PubMed ID: 9122396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complications of prostaglandin E1 treatment of congenital heart disease in paediatric medical intensive care].
    Lucron H; Chipaux M; Bosser G; Le Tacon S; Lethor JP; Feillet F; Burger G; Monin P; Marçon F
    Arch Mal Coeur Vaiss; 2005 May; 98(5):524-30. PubMed ID: 15966603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilation of the ductus arteriosus by oral prostaglandin E1 derivative in cyanotic congenital heart diseases.
    Matsuura H; Saji T; Yamamoto S; Ishikita T; Aoki Y; Matsuo N
    Am Heart J; 1993 May; 125(5 Pt 1):1453-4. PubMed ID: 8480610
    [No Abstract]   [Full Text] [Related]  

  • 18. Enteral feeding in prostaglandin-dependent neonates: is it a safe practice?
    Willis L; Thureen P; Kaufman J; Wymore E; Skillman H; da Cruz E
    J Pediatr; 2008 Dec; 153(6):867-9. PubMed ID: 19014824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to prostaglandin E1 in neonates with intracranial arteriovenous malformation treated for suspected congenital heart disease.
    Covert RF
    Pediatr Cardiol; 1994; 15(2):81-4. PubMed ID: 7997419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.